Medicare Enrolled
Dr. Frank Moore, MD
Urology Physician · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moore?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moore
Dr. Frank Moore is an urology physician in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Moore performed 5,722 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Moore received a total of $9,554 from 56 pharmaceutical and/or device companies across 377 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in TX
$9,554 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,722
Medicare services
Top 20% in TX for urology physician
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
952 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
728 | $86 | $281 |
| Leuprolide injectable, camcevi, 1 mg | 504 | $67 | $194 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
493 | $6 | $13 |
| PSA test (prostate cancer screening) | 391 | $18 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $63 | $204 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
304 | $8 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
191 | $115 | $367 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
146 | $180 | $543 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
137 | $18 | $41 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
135 | $69 | $312 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
112 | $8 | $19 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
100 | $25 | $57 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
92 | $16 | $51 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
90 | $34 | $351 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
90 | $34 | $195 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
90 | $34 | $117 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
89 | $6 | $14 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
76 | $129 | $399 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
64 | $0 | $1 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
56 | $2 | $5 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
45 | $34 | $78 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
45 | $34 | $78 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
45 | $34 | $78 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
45 | $34 | $78 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
45 | $34 | $78 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
45 | $34 | $78 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
32 | $109 | $312 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
31 | $551 | $1,598 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $11 | $31 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $62 | $157 |
| New patient office visit, complex (60-74 min) | 19 | $165 | $487 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
18 | $27 | $62 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $177 | $499 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $27 | $77 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
14 | $2 | $5 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
14 | $2 | $5 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
14 | $21 | $91 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $101 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,554
Total received (2018-2024)
Avg $1,365/year across 7 years
Top 21% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
377
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,363
2023
$1,065
2022
$1,004
2021
$1,733
2020
$526
2019
$2,382
2018
$1,482
Payments by company (2024)
ABBVIE INC.
$271
Teleflex LLC
$169
Dendreon Pharmaceuticals LLC
$165
Olympus America Inc.
$101
UROGEN PHARMA, INC.
$79
Blue Earth Diagnostics Limited
$69
Merck Sharp & Dohme LLC
$69
Axonics, Inc.
$60
Sumitomo Pharma America, Inc.
$47
PROGENICS PHARMACEUTICALS, INC.
$47
PROCEPT BioRobotics Corporation
$38
STERIS CORPORATION
$37
Calyxo, Inc.
$32
Janssen Biotech, Inc.
$26
AngioDynamics, Inc.
$25
Laborie Medical Technologies Corp.
$25
CIVCO Medical Instruments
$19
Verity Pharmaceuticals Inc.
$17
Tolmar, Inc.
$16
Photocure Inc
$16
ACCORD HEALTHCARE, INC.
$14
Myriad Genetic Laboratories, Inc.
$13
Mission Pharmacal Company
$7
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$2,061
Astellas Pharma US Inc
$1,180
ABBVIE INC.
$675
Teleflex LLC
$494
Janssen Biotech, Inc.
$465
Dendreon Pharmaceuticals LLC
$423
Blue Earth Diagnostics Limited
$371
Boston Scientific Corporation
$329
Myovant Sciences Inc.
$320
BOSTON SCIENTIFIC CORPORATION
$261
AbbVie, Inc.
$198
PROCEPT BioRobotics Corporation
$172
Sumitomo Pharma America, Inc.
$169
Merck Sharp & Dohme LLC
$165
UROVANT SCIENCES INC
$130
Impulse Dynamics (USA) Inc.
$116
TOLMAR Pharmaceuticals, Inc.
$110
Innovation Technologies Inc
$109
UROGEN PHARMA, INC.
$103
AbbVie Inc.
$102
Olympus America Inc.
$101
Endo Pharmaceuticals Inc.
$99
Ferring Pharmaceuticals Inc.
$98
Bayer HealthCare Pharmaceuticals Inc.
$94
GENZYME CORPORATION
$89
BIOTISSUE HOLDINGS, INC.
$88
Progenics Pharmaceuticals, Inc.
$82
Myriad Genetic Laboratories, Inc.
$68
Retrophin, Inc.
$63
Axonics, Inc.
$60
Clarus Therapeutics Inc.
$55
Mission Pharmacal Company
$54
HealthTronics Mobile Solutions, LLC
$48
PROGENICS PHARMACEUTICALS, INC.
$47
Laborie Medical Technologies Corp.
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
Travere Therapeutics, Inc.
$42
COLOPLAST CORP
$39
STERIS CORPORATION
$37
Avadel Specialty Pharmaceuticals, LLC
$37
Calyxo, Inc.
$32
AstraZeneca Pharmaceuticals LP
$31
Tolmar, Inc.
$30
AngioDynamics, Inc.
$25
Accord Healthcare, Inc.
$20
Covidien LP
$19
CIVCO Medical Instruments
$19
PFIZER INC.
$18
Verity Pharmaceuticals Inc.
$17
UroGen Pharma, Inc.
$17
Photocure Inc
$16
ACCORD HEALTHCARE, INC.
$14
Rochester Medical Corporation
$14
Medtronic, Inc.
$14
Antares Pharma, Inc.
$13
NxThera, Inc.
$7
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Androgel · Axumin · BOTOX · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSVIEW · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GREENLIGHT · General - Therapies · INTERSTIM · IRRISEPT · ImaJin · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · NANOKNIFE · NEOX · NOCDURNA · Noctiva · Nubeqa · OPTIMIZER · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROSTATE CANCER - DISEASE · PROVENGE · PYLARIFY · Prolaris · REZUM · ReTrace · Rezum · Thiola · Trelstar · UPHOLD LITE · URIBEL TABS · UROLIFT · Uretero1 · Uribel · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iDrive · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
79
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moore is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moore experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Moore performed 952 urinalysis, manual services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Moore receive payments from pharmaceutical companies?
Yes. Dr. Moore received a total of $9,554 from 56 companies across 377 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moore's costs compare to other urology physicians in Fort Worth?
Dr. Moore's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fort Worth
Browse urology physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology